Recently, in this journal (1943) , the writer reviewed evidence pertaining to the possible r6le of nutritional deficiency as a contributory factor in the aetiology of rheumatic fever. In this report it was shown that a series of experimental, epidemiological and clinical considerations implicated vitamin C deficiency as a factor in the pathogenesis of rheumatic fever. While vitamin C deficiency may be important in predisposing to the initial attack of rheumatic fever and may, per se, be of some value in treatment, ascorbic acid has failed to exert any marked influence on the course of the illness or to prevent recurrences.
In 1941 we became interested in the possible therapeutic value of vitamin P in rheumatic fever and, in the paper referred to, reported on the apparent favourable influence of this substance in 3 cases of persistently active rheumatic fever. Subsequently, we recorded preliminary observations on small numbers of cases of rheumatic fever so treated (1944) . Vitamin P was so designated because of its reputed influence on capillary permeability. In the excellent original report of Armentano and his colleagues (1936) Emphasis has been placed upon the sedimentation rate in this study because it is the most critical objective index of activity and gauge of progress in cases in which the diagnosis of rheumatic fever is established. In many it was the only definite evidence of continued active disease. Insofar as other manifestations of activity existed, improvement occurred which paralleled the slowing sedimentation rate.
Discussion
It is considered highly probable by the writer that the slowing of the sedimentation rate in the cases reported is related to the treatment. This is believed to be so particularly in the persistent cases where clinical observations indicated prolonged activity prior to treatment. It will be noted by reference to Figs. I and 2 that many cases showed significant slowing of the sedimentation rate within 2 weeks. The cases of relatively short duration, although showing similar responses, are less convincing in that spontaneous recovery is frequently observed in a 4 to 6 week period. Although the persistent cases act to some extent as their own control, it is naturally desirable to extend the studies utilizing alternate cases as controls. This is being done at the present time, and the data now available indicates that the treated cases are showing more favourable response than the untreated controls.
It should be pointed out that in the cases studied, vitamin P was given as additional therapy, i.c. it was added to the therapeutic regime of the patient at the time study of the case was undertaken. Although it has not been studied, we Szent-Gyorgyi (1939) , deficiency of this factor would block effective utilization of ascorbic acid. Also, it is of interest that the cases of vascular purpura which are reported as benefited by vitamin P are generally considered to be of allergic nature. There is considerable evidence that an allergic mechanism operates in rheumatic fever.
In view of the great importance of rheumatic fever as a cause of cardiac disability and death, studies of promise should be pursued with vigour. If nutritional deficiency is a contributory aetiologic factor, it is evident that prevention would be feasible.
Summary
Observations are recorded in 39 cases of rheumatic fever treated with vitamin P. Evidence is presented that this substance exerts a beneficial influence on the course of the illness as reflected chiefly by slowing the sedimentation rate. Extension of studies on the application of vitamin P in treatment and prophylaxis of rheumatic fever are indicated.
